Daily Intake of Multivitamin & Mineral Supplementation Effects on Biological Age of Relatively Healthy Middle-aged Individuals
Study acronym: CEDIRA
StatusRecruiting
PhaseNot applicable
Started2024-09-23
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 30, 2024 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
68 trials monitored
See 4 trials at risk
Micronutrients, such as vitamins and minerals, are required to sustain fundamental physiological processes in individuals. As individuals age, the risk of having suboptimal levels of micronutrients increases due to several age-related changes affecting their digestion and assimilation processes. Suboptimal levels of micronutrients have been associated with increased risk of chronic diseases and accelerated ageing. Three years intake of a multivitamin and mineral supplement (MVM) improved global cognition, episodic memory and executive function in older adults. Furthermore, suboptimal micronutrient levels have been associated with a higher biological age, and diet and lifestyle interventions might lower the biological age measured by methylation clocks. Therefore, further evaluation is warranted to determine if MVM supplementation could improve the biological age and clinical outcomes in individuals with a higher biological age.
| NCT Number |
NCT06666660 |
| Lead Sponsor |
National University of Singapore
Collaborators: HALEON |
| Conditions |
Relatively Healthy Volunteers |
| Enrollment |
400 participants |
| Start Date |
2024-09-23 |
| Primary Completion |
2025-04-30 (estimated) |
| Study Completion |
2025-06-30 (estimated) |
| Updated on ClinicalTrials.gov |
2024-10-30 |